BMC Cancer (Jul 2008)

Localization of hRad9 in breast cancer

  • Suen Dacita,
  • Lau Ken,
  • Wong MS,
  • Khoo US,
  • Chan Vivian,
  • Li George,
  • Kwong Ava,
  • Chan TK

DOI
https://doi.org/10.1186/1471-2407-8-196
Journal volume & issue
Vol. 8, no. 1
p. 196

Abstract

Read online

Abstract Background hRad9 is a cell cycle checkpoint gene that is up-regulated in breast cancer. We have previously shown that the mRNA up-regulation correlated with tumor size and local recurrence. Immunohistochemical studies were made to better define the role of hRad9 in breast carcinogenesis. Methods Localisation of hRad9 protein were performed on paired tumor and normal breast tissues. Immunoblotting with and without dephosphorylation was used to define the protein isolated from breast cancer cells. Results Increased hRad9 protein was observed in breast cancer cells nucleus compared to non-tumor epithelium. This nuclear protein existed in hyperphosphorylated forms which may be those of the hRad9-hRad1-hHus1 complex. Conclusion Finding of hyperphosphorylated forms of hRad9 in the nucleus of cancer cells is in keeping with its function in ameliorating DNA instability, whereby it inadvertently assists tumor growth.